"Rates of heart disease, cancer, diabetes, and other noncommunicable diseases (NCDs) in low- and middle-income countries are increasing faster, in younger people, and with worse outcomes than in wealthier countries. In 2013 alone, NCDs killed eight million people before their sixtieth birthdays...

This paper advocates changes in the corporate governance of the World Trade Organization (WTO) to reflect the decline in tariffs and other border restraints to commerce and the emerging challenges of advancing freer trade and better regulation cooperation in a world economy dominated by global...

Many months after COVID-19 vaccines were first authorized for public use, still limited supplies could only partially reduce the devastating loss of life and economic costs caused by the pandemic. Could additional vaccine doses have been manufactured more quickly some other way? Would...

The United States has trade deals with pharmaceutical terms that go beyond the requirements in World Trade Organization (WTO) agreements with 17 countries. Some are more than a decade old, but just two studies have ever assessed how those trade agreements affected prices in practice. This...

Intellectual property rights have long dominated treatment access scholarship and debates, but are at present neither the cause nor the solution for the inaccessibility of treatments for the neglected diseases that afflict the world’s poorest. Prizes and grants have helped stimulate research...